99% Savings - Buy Just @1 Rs X
Cabgolin 0.25 Mg Tablet is a prescription drug, available for use as Tablet. Acromegaly, Prolactinoma are some of its major therapeutic uses.
The optimal dosage of Cabgolin 0.25 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Cabgolin 0.25 Mg Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Cabgolin 0.25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Cabgolin 0.25 Mg Tablet's effect during pregnancy is Mild and Severe while nursing. In addition, Cabgolin 0.25 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Cabgolin 0.25 Mg Tablet related warnings section.
Cabgolin 0.25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. High BP (High Blood Pressure), Heart Disease, Depression are examples of such conditions. Other contraindications of Cabgolin 0.25 Mg Tablet have been discussed in the sections ahead.
Besides this, Cabgolin 0.25 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Cabgolin 0.25 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Cabgolin 0.25 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cabgolin 0.25 Mg Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Cabgolin has mild side effects when taken during pregnany
Is the use of Cabgolin 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Cabgolin. So it is adviced to consult the doctor before using it.
What is the effect of Cabgolin 0.25 Mg Tablet on the Kidneys?
Kidney can be affected by Cabgolin. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Cabgolin 0.25 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Cabgolin. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cabgolin 0.25 Mg Tablet on the Heart?
The heart can be affected by Cabgolin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Cabgolin 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Cabgolin 0.25 Mg Tablet habit forming or addictive?
Cabgolin 0.25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Cabgolin 0.25 Mg Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Cabgolin 0.25 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Cabgolin 0.25 Mg Tablet for mental disorders.
Interaction between Food and Cabgolin 0.25 Mg Tablet
There is no information on the effects of taking Cabgolin 0.25 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Cabgolin 0.25 Mg Tablet
Chances of side effects of drinking alcohol while taking Cabgolin 0.25 Mg Tablet are low. If you feel any adverse effects, please seek medical advice as soon as possible.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)